Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02740140
Other study ID # SU-10182007-743
Secondary ID
Status Completed
Phase N/A
First received September 1, 2011
Last updated April 14, 2016
Start date June 2008
Est. completion date July 2013

Study information

Verified date April 2016
Source Stanford University
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Observational

Clinical Trial Summary

This observational epidemiologic study with nested cross-sectional and longitudinal aims will evaluate host immune response to mixed chronic infections (Helicobacter pylori, latent tuberculosis, intestinal helminthiasis) in recent US immigrants.


Description:

1750 clinically-well, adult (age 18-55 years), recent immigrants (<2 years U.S. residence), referred through cooperating public health clinics in the Santa Clara Valley area, CA will be screened for H. pylori, helminth, and latent tuberculosis infections ["Screening" population]. Of these 1750, 426 will be selected for more intensive study (Cohort population), 105 of whom will receive baseline endoscopy. Of those selected for the cohort, 300 are expected to complete a 9-month follow-up assessment, 75 of whom are expected to undergo a second follow-up endoscopy.


Recruitment information / eligibility

Status Completed
Enrollment 1750
Est. completion date July 2013
Est. primary completion date June 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria:

- Between 18-55 years of age

- Either sex

- If female not pregnant or breastfeeding

- Lived in the United States less than 2 years

- Healthy

- Scheduled for Tuberculosis Skin Test (TST)

Exclusion Criteria:

- Under 18 and older than 55 years of age,

- Pregnant or breastfeeding

- Have lived in Unites States more that 2 years

- Chronic illness

- Not planning to get a TST

Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


Locations

Country Name City State
United States Santa Clara Public Health Clinics San Jose California
United States Stanford University School of Medicine Stanford California

Sponsors (2)

Lead Sponsor Collaborator
Stanford University Santa Clara Valley Health & Hospital System

Country where clinical trial is conducted

United States, 

References & Publications (4)

Chang AH, Perry S, Du JN, Agunbiade A, Polesky A, Parsonnet J. Decreasing intestinal parasites in recent Northern California refugees. Am J Trop Med Hyg. 2013 Jan;88(1):191-7. doi: 10.4269/ajtmh.2012.12-0349. Epub 2012 Nov 13. — View Citation

Herrera V, Perry S, Parsonnet J, Banaei N. Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection. Clin Infect Dis. 2011 Apr 15;52(8):1031-7. doi: 10.1093/cid/cir068. Review. — View Citation

Perry S, Chang AH, Sanchez L, Yang S, Haggerty TD, Parsonnet J. The immune response to tuberculosis infection in the setting of Helicobacter pylori and helminth infections. Epidemiol Infect. 2013 Jun;141(6):1232-43. doi: 10.1017/S0950268812001823. Epub 2012 Sep 7. — View Citation

Perry S, Hussain R, Parsonnet J. The impact of mucosal infections on acquisition and progression of tuberculosis. Mucosal Immunol. 2011 May;4(3):246-51. doi: 10.1038/mi.2011.11. Epub 2011 Mar 16. Review. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Change in cytokine responses from baseline at 9 months in TB and H. pylori antigen-induced PBMC before and after provider managed treatment of latent TB or helminth infection Baseline and 9 months after treatment for either latent TB or helminth infections; analyzed after all subjects recruited (3 years of recruitment plus 9 months follow-up). No
Secondary Correlation of cytokine response to TB antigens and helminths with humoral responses to infections with H. pylori. Assays performed when collected over three years from recruited subjects; analyzed at the end of three years. No
Secondary Population prevalence of individual and joint infections with H pylori, latent tuberculosis, heminthiasis in recent immigrant to northern California We compare prevalence of these infections in recent immigrants by geographic area Assays performed when collected over three years from recruited subjects; analyzed at the end of three years. No
See also
  Status Clinical Trial Phase
Completed NCT03120975 - Computerized Antibiotic Stewardship Study N/A
Recruiting NCT06112249 - SAFE Workplace Intervention for People With IDD N/A
Recruiting NCT05394363 - Generation Victoria Cohort 2020s: A Statewide Longitudinal Cohort Study of Victorian Children and Their Parents
Completed NCT01232686 - Snow Disease Surveillance System Study N/A
Completed NCT06133400 - Mapping the Health Status of the Population of French Polynesia: the MATAEA Project N/A
Enrolling by invitation NCT02338986 - Collection of Plasma From People Who Recovered From or Were Vaccinated to Emerging Infectious Diseases
Recruiting NCT06164600 - Bovine Colostrum for Prophylaxis Against Recurrent Urinary Tract Infection in Children Phase 2
Completed NCT03931941 - Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection (PUNCH CD3-OLS) Phase 3
Completed NCT02434848 - A Pilot Study Comparing the Immunogenicity of Fendrix vs. Double-dose Engerix B in HIV-infected Non-responders to Standard Hepatitis B Vaccination Courses Phase 2/Phase 3
Completed NCT02606981 - Automatic Chlorination and Child Health in Urban Bangladesh N/A
Completed NCT02046512 - Probiotics to Promote Intestinal Health Phase 4
Completed NCT00140335 - Evaluation of a Handwashing Promotion Program in Chinese Elementary Schools Phase 4
Completed NCT01873040 - Vaccine Social Media Randomized Intervention Trial N/A
Enrolling by invitation NCT02422875 - Comparative Autoantibody and Immunologic Cell Marker Study
Completed NCT00001477 - Monitoring Patients for Developing Communicable and Opportunistic Infections and for Responding to Therapy N/A
Completed NCT02665013 - Reducing Delay of Vaccination in Children Study N/A
Completed NCT04603313 - Opinion of the Infectious Disease Specialist Referent for the Good Use of AnTiBiotics
Active, not recruiting NCT03894566 - NASCITA Italian Birth Cohort Study
Withdrawn NCT00006630 - Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection Phase 1